Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company based in Oxford, U.K. Subject to customary closing conditions, completion of the transaction is expected in the third quarter of this calendar year.
Molecular Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.
-
-
Raza Alvi, M.D., a research fellow in radiology at Massachusetts General Hospital, has been involved in a study of a positron-emission...
-
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and patients alike a positive outlook in nuclear medicine.
-
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S. Food & Drug Administration (FDA) clearance of the uExplorer total-body scanner.
-
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 Radiological Society of North America (RSNA) meeting.
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along...
A 3-D printed tungsten pre-clinical X-ray system collimator. The tungsten alloy powder is printed into the form desired and is laser fused so it can be machined and finished. Previously, making collimators from Tungsten was labor intensive because it required working with sheets of the metal to create the collimator matrix.
Feature | Medical 3-D Printing | September 04, 2019 | By Steve Jeffery
In ...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.
Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly...
Sponsored Content
News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and...
Image courtesy of the University of Alabama at Birmingham
News | Radiopharmaceuticals and Tracers | August 29, 2019
August 27, 2019 — The University of Alabama at Birmingham, in conjunction with researchers at the University of...
News | PET-CT | August 15, 2019
August 15, 2019 — United Imaging announced that its uExplorer total-body...
News | Radiopharmaceuticals and Tracers | August 02, 2019
August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR...
Sponsored Content
Staging F18FDG PET/CT images of adenocarcinoma in the RUL (right upper lobe) of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. (Images courtesy of Dr. Jay Kikut and UVMC)
Blog | PET-CT | October 25, 2018
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both.
News | Interventional Radiology | July 31, 2019
July 31, 2019 — New consensus recommendations for personalized treatment for hepatocellular carcinoma (HCC) with BTG’s...
News | Radiopharmaceuticals and Tracers | July 26, 2019
July 26, 2019 — NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U....
News | Radiopharmaceuticals and Tracers | July 16, 2019
July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot...
News | Radiopharmaceuticals and Tracers | July 01, 2019
July 1, 2019 — Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a...
Image courtesy of Philips Healthcare
Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging. With a mass preference...
Technology | Information Technology | June 20, 2019
June 20, 2019 — DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
News | PET-CT | June 19, 2019
June 19, 2019 — United Imaging announced the first U.S. clinical installation of the uMI 550 Digital...
X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.
News | Computed Tomography (CT) | June 17, 2019
June 17, 2019 — An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10...
Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.
News | Magnetic Resonance Imaging (MRI) | June 07, 2019
June 7, 2019 — The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best...
News | Radiopharmaceuticals and Tracers | June 05, 2019
June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel...
News | Radiation Therapy | May 31, 2019
May 31, 2019 — RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters...
Image courtesy of MR Solutions.
News | PET-MRI | May 23, 2019
May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide...
News | Radiopharmaceuticals and Tracers | May 17, 2019
May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b...
News | Radiopharmaceuticals and Tracers | May 13, 2019
May 13, 2019 — Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F))...
